Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Alexion Pharm Inc (ALXN)

Alexion Pharm Inc (ALXN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 23,706,904
  • Shares Outstanding, K 221,291
  • Annual Sales, $ 4,131 M
  • Annual Income, $ 77,600 K
  • 60-Month Beta 1.65
  • Price/Sales 5.86
  • Price/Cash Flow 12.11
  • Price/Book 2.31

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 2.27
  • Number of Estimates 10
  • High Estimate 2.46
  • Low Estimate 2.19
  • Prior Year 1.95
  • Growth Rate Est. (year over year) +16.41%

Price Performance

See More
Period Period Low Period High Performance
1-Month
97.58 +8.51%
on 10/18/19
111.04 -4.64%
on 11/08/19
+4.55 (+4.49%)
since 10/14/19
3-Month
94.59 +11.95%
on 10/09/19
125.52 -15.64%
on 08/22/19
-1.76 (-1.63%)
since 08/14/19
52-Week
92.56 +14.40%
on 12/24/18
141.86 -25.36%
on 04/10/19
-10.22 (-8.80%)
since 11/14/18

Most Recent Stories

More News
The Zacks Analyst Blog Highlights: AMETEK, Thermo Fisher Scientific, IQVIA, Lowe's Companies and Alexion Pharmaceuticals

The Zacks Analyst Blog Highlights: AMETEK, Thermo Fisher Scientific, IQVIA, Lowe's Companies and Alexion Pharmaceuticals

LOW : 114.54 (+1.50%)
TMO : 300.84 (+0.27%)
ALXN : 105.89 (-1.16%)
AME : 97.00 (+0.99%)
Alexion (ALXN) Up 10 % YTD on Soliris & Ultomiris Strength

Alexion's (ALXN) stock rises 10% in the year so far as Soliris maintains momentum and Ultomiris gains further traction.

AMGN : 218.50 (-0.53%)
ACHN : 6.34 (+0.16%)
ALXN : 105.89 (-1.16%)
MITO : 7.73 (+8.26%)
Alexion (ALXN) is an Incredible Growth Stock: 3 Reasons Why

Alexion (ALXN) is well positioned to outperform the market, as it exhibits above-average growth in financials.

ALXN : 105.89 (-1.16%)
5 Most-Loved S&P 500 Stocks on Wall Street

Given the bullishness and record-high market, we have screened for five S&P 500 stocks that are most loved by the brokerage firms.

LOW : 114.54 (+1.50%)
TMO : 300.84 (+0.27%)
ALXN : 105.89 (-1.16%)
AME : 97.00 (+0.99%)
IQV : 145.70 (+1.48%)
Alexion to Present at the 2019 Stifel Healthcare Conference

Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that management will present at the 2019 Stifel Healthcare Conference in New York, NY on Tuesday, November 19th, 2019 at 8:35 a.m. ET.

ALXN : 105.89 (-1.16%)
Fortress Biotech Reports Third Quarter 2019 Financial Results and Recent Corporate Highlights

Fortress Biotech, Inc. (NASDAQ: FBIO) ("Fortress"), an innovative biopharmaceutical company focused on identifying, in-licensing and developing high-potential marketed and development-stage drugs and drug...

FBIO : 1.65 (+1.85%)
ALXN : 105.89 (-1.16%)
Celgene (CELG) Hits 52-Week High, Can the Run Continue?

Celgene (CELG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

CELG : 110.02 (-0.35%)
REGN : 338.39 (-2.85%)
ALXN : 105.89 (-1.16%)
GHDX : 63.44 (-0.69%)
Watch for Alexion Pharm to Potentially Pullback After Gaining 8.19% Yesterday

Alexion Pharm (NASDAQ:ALXN) traded in a range yesterday that spanned from a low of $107.00 to a high of $109.83. Yesterday, the shares gained 8.2%, which took the trading range above the 3-day high of...

ALXN : 105.89 (-1.16%)
Pharma Sector Tops in October: Best ETFs & Stocks

Pharma sector wins in October, making these ETFs and stocks winners.

PPH : 60.21 (-0.43%)
XPH : 38.20 (-0.13%)
PJP : 59.78 (-0.33%)
ALXN : 105.89 (-1.16%)
BIIB : 275.15 (-2.39%)
ACHN : 6.34 (+0.16%)
DERM : 7.53 (-6.92%)
GLYC : 6.50 (+3.83%)
RIGL : 2.29 (-2.14%)
IRWD : 11.60 (+1.98%)
Achillion Reports Third Quarter 2019 Financial Results and Provides Corporate Update

- Reached an agreement to be acquired by Alexion;

ALXN : 105.89 (-1.16%)
ACHN : 6.34 (+0.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Good. Long term indicators fully support a continuation of the trend.

See More Share

Trade ALXN with:

Business Summary

Alexion Pharmaceuticals, Inc. is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the innovation, development and commercialization of life-changing therapies. Alexion is the global leader in complement inhibition and has developed and commercializes...

See More

Key Turning Points

2nd Resistance Point 109.32
1st Resistance Point 107.61
Last Price 105.89
1st Support Level 104.35
2nd Support Level 102.80

See More

52-Week High 141.86
Fibonacci 61.8% 123.03
Fibonacci 50% 117.21
Fibonacci 38.2% 111.39
Last Price 105.89
52-Week Low 92.56

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar